// App-Quantinova.ai

656 : Prostaglandin E2 and Its Receptor Subtype EP4 Are Involved in Ankylosing Spondylitis Disease Progression

Researchers

Presenter

  • Archita Srinath

Principal Investigators

  • Giuliana Guggino

  • Ismail Sari

  • Fanxing Zeng

  • Francesco Ciccia

  • Nigil Haroon

Medical Centers

  • Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada

  • Genetics and developmental biology, University Health Network, Toronto, ON, Canada

  • Krembil Discovery Tower, Toronto, ON, Canada

  • Hematology Unit, Universit di Palermo, Palermo, Italy

  • Toronto General Hospital, University of Toronto, Toronto, ON, Canada

  • Universtiy Health Network, Toronto, ON, Canada

Locations

  • Canada

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • Peripheral blood mononuclear cell

  • Prostaglandin E2

  • Transcription factor Maf

Drug/Treatment

  • Dinoprostone

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A